Poolbeg Pharma Reports Positive Interim Review of POLB 001 Trial

Watch on YouTube

Poolbeg Pharma has announced a positive interim safety review from the TOPICAL clinical trial of POLB 001, with the study recommended to continue as planned and no changes required to the protocol. Recruitment is continuing at UK clinical sites, with further patients expected to enrol and additional sites set to be activated as the company progresses the trial and generates further data for prospective partners.